Big Pharma: sorry, the Golden Age is over!
“People who invest in pharma companies have to expect, not as a permanent condition, but as a long term trend, a lower rate of return than they had during the golden blockbuster years…”
Armstrong, Drew. Drugmakers’ Returns on Research Fall as Pipeline Projects Fail. Bloomberg.com, online, posted on Nov. 21, 2011.